MiniMed Group, Inc. (MMED)

MiniMed Group Balance Sheet

Financials in millions USD. Fiscal year is May - April.

Year Ending	TTM	Apr 25, 2025	Apr 25, 2024	Apr 25, 2023
Cash & Equivalents	8	11	54	-
Cash & Cash Equivalents	8	11	54	0
Cash Growth	-	-79.63%	-	-
Receivables	588	570	507	-
Inventory	361	311	292	-
Other Current Assets	34	47	42	-
Total Current Assets	991	939	895	-
Property, Plant & Equipment	-	706	636	-
Goodwill and Intangibles	-	151	177	-
Other Long-Term Assets	-	2,405	2,386	-
Total Long-Term Assets	-	3,262	3,199	-
Total Assets	-	4,201	4,094	-
Accounts Payable	-	205	190	-
Other Current Liabilities	560	505	328	-
Total Current Liabilities	560	710	518	-
Other Long-Term Liabilities	-	161	129	-
Total Long-Term Liabilities	-	161	129	-
Total Liabilities	-	871	647	-
Comprehensive Income	-	3	-16	-
Shareholders' Equity	3,560	3,330	3,448	-
Net Cash (Debt)	8	11	54	0
Net Cash (Debt) Growth	-	-79.63%	-	-
Working Capital	431	229	377	-

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).